| Literature DB >> 29602445 |
María T Elola1, Fátima Ferragut2, Santiago P Méndez-Huergo3, Diego O Croci4, Candelaria Bracalente2, Gabriel A Rabinovich5.
Abstract
Tumor cells corrupt surrounding normal cells instructing them to support proliferative, pro-angiogenic and immunosuppressive networks that favor tumorigenesis and metastasis. This dynamic cross-talk is sustained by a range of intracellular signals and extracellular mediators produced by both tumoral and non-tumoral cells. Galectins -whether secreted or intracellularly expressed- play central roles in the tumorigenic process by delivering regulatory signals that contribute to reprogram fibroblasts, endothelial and immune cell programs. Through glycosylation-dependent or independent mechanisms, these endogenous lectins control a variety of cellular events leading to tumor cell proliferation, survival, migration, inflammation, angiogenesis and immune escape. Here we discuss the role of galectin-driven pathways, particularly those activated in non-tumoral stromal cells, in modulating tumor progression.Entities:
Keywords: Endothelial cells; Fibroblasts; Galectins; Immune cells; Tumor microenvironment
Mesh:
Substances:
Year: 2018 PMID: 29602445 DOI: 10.1016/j.cellimm.2018.03.008
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868